Petr Pavlis
Overview
Explore the profile of Petr Pavlis including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
7
Citations
18
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Bouska O, Jaworek H, Koudelakova V, Kubanova K, Dzubak P, Slavkovsky R, et al.
Viruses
. 2022 Dec;
14(12).
PMID: 36560833
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has caused considerable disruption worldwide. For efficient SARS-CoV-2 detection, new methods of rapid, non-invasive sampling are needed. This study aimed to investigate the...
2.
Borkova L, Frydrych I, Vranova B, Jakubcova N, Liskova B, Gurska S, et al.
Eur J Med Chem
. 2022 Oct;
244:114850.
PMID: 36283179
In this work, a large set of betulinic acid derivatives modified with various aromatic substituents at the position C-3 were prepared via Suzuki-Myiaura cross-coupling. All compounds were tested for their...
3.
Yang C, Slavetinska L, Fleuti M, Klepetarova B, Tichy M, Gurska S, et al.
J Am Chem Soc
. 2022 Oct;
144(42):19437-19446.
PMID: 36245092
A new approach for synthesizing polycyclic heterofused 7-deazapurine heterocycles and the corresponding nucleosides was developed based on C-H functionalization of diverse (hetero)aromatics with dibenzothiophene--oxide followed by the Negishi cross-cooupling with...
4.
Tanoli Z, Aldahdooh J, Alam F, Wang Y, Seemab U, Fratelli M, et al.
Brief Bioinform
. 2021 Sep;
23(1).
PMID: 34472587
Chemosensitivity assays are commonly used for preclinical drug discovery and clinical trial optimization. However, data from independent assays are often discordant, largely attributed to uncharacterized variation in the experimental materials...
5.
Tanoli Z, Aldahdooh J, Alam F, Wang Y, Seemab U, Fratelli M, et al.
bioRxiv
. 2020 Dec;
PMID: 33300000
Chemosensitivity assays are commonly used for preclinical drug discovery and clinical trial optimization. However, data from independent assays are often discordant, largely attributed to uncharacterized variation in the experimental materials...
6.
Fleuti M, Bartova K, Slavetinska L, Tloustova E, Tichy M, Gurska S, et al.
J Org Chem
. 2020 Jul;
85(16):10539-10551.
PMID: 32692916
A series of 8-substituted 1-methyl-1,4-dihydropyrazolo[3',4':4,5]pyrrolo[2,3-]pyrimidine (methylpyrazolo-fused 7-deazapurine) ribonucleosides have been designed and synthesized. Two synthetic approaches to the key heterocyclic aglycon , (i) a six-step classical heterocyclization starting from 5-chloro-1-methyl-4-nitropyrazole...
7.
Yang C, Pohl R, Tichy M, Gurska S, Pavlis P, Dzubak P, et al.
J Org Chem
. 2020 May;
85(12):8085-8101.
PMID: 32432875
Two isomeric series of benzothieno-fused 7-deazapurine (benzo[4',5']thieno[3',2':4,5]- and benzo[4',5']thieno[2',3':4,5]pyrrolo[2,3-]pyrimidine) ribonucleosides were designed and synthesized. Key steps of the synthesis included the Negishi coupling of zincated dichloropyrimidine with 2- or 3-iodobenzothiophene...